NowCardio Receives Certification $ECGI NEW YOR
Post# of 33
Posted On: 02/26/2016 10:42:28 AM
NowCardio Receives Certification $ECGI
NEW YORK, NY--(Marketwired - February 26, 2016) - Event Cardio Group Inc. (OTCQB: ECGI), a medical device company, is pleased to announce that its (Advanced Ambulatory Arrhythmia Monitoring System), NowCardio™, has successfully been certified to Canadian Medical Devices Conformity Assessment System (CMDCAS), ISO 13485:2003, and ISO 9001:2008. The certification was performed by a recognized registrar, BSI Group, and is a significant advancement towards the commercialization of NowCardio™ within North American Markets.
NowCardio™ is an (Advanced Ambulatory Arrhythmia Monitoring System) that will be used to monitor, analyze, record, and transmit a patient's heart's physiological data in real-time. NowCardio™ offers the functionality of Holter Monitoring, Event Recording, and Mobile Cardiac Telemetry all within a single device. The NowCardio™ system is configurable, enabling a single device to serve multiple segments within the Cardiac Diagnostic Marketplace.
John Bentivoglio, Chief Executive Officer and President of Event Cardio Group, stated, "The certification is a major milestone for NowCardio™ and we are moving forward with our commercialization plan to bring this innovative product to market in 2016. We believe that NowCardio™ is positioned to be a game changer within the Cardiac Diagnostic Marketplace. "
About Event Cardio Group Inc.
NEW YORK, NY--(Marketwired - February 26, 2016) - Event Cardio Group Inc. (OTCQB: ECGI), a medical device company, is pleased to announce that its (Advanced Ambulatory Arrhythmia Monitoring System), NowCardio™, has successfully been certified to Canadian Medical Devices Conformity Assessment System (CMDCAS), ISO 13485:2003, and ISO 9001:2008. The certification was performed by a recognized registrar, BSI Group, and is a significant advancement towards the commercialization of NowCardio™ within North American Markets.
NowCardio™ is an (Advanced Ambulatory Arrhythmia Monitoring System) that will be used to monitor, analyze, record, and transmit a patient's heart's physiological data in real-time. NowCardio™ offers the functionality of Holter Monitoring, Event Recording, and Mobile Cardiac Telemetry all within a single device. The NowCardio™ system is configurable, enabling a single device to serve multiple segments within the Cardiac Diagnostic Marketplace.
John Bentivoglio, Chief Executive Officer and President of Event Cardio Group, stated, "The certification is a major milestone for NowCardio™ and we are moving forward with our commercialization plan to bring this innovative product to market in 2016. We believe that NowCardio™ is positioned to be a game changer within the Cardiac Diagnostic Marketplace. "
About Event Cardio Group Inc.
(0)
(0)